Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

University of Saskatchewan

$120,000.00

Investigating the molecular mechanisms of synaptic pathology in multiple sclerosis through dysfunction of heterogeneous nuclear ribonucleoprotein A1

FY 2025-26

Summary
Multiple sclerosis (MS) is an inflammatory disease that causes chronic damage to the brain and spinal cord. Damage to nerve cells is what drives long-term disability and disease worsening. Research has shown that the tiny connections between nerve cells, called synapses, are also affected in the brains of people living with MS. Synapses are essential for communication in the brain because they allow nerve cells to send signals that control movement, memory, and cognition. In MS, these connections become disrupted or lost, which contributes to depression, fatigue, and difficulties with learning, memory, and challenges in performing daily activities. However, there are no available therapies for protecting brain function because we do not fully understand how nerve cell connections are lost. Our lab focuses on studying nerve cells, with the goal of addressing this knowledge and therapeutic gap in MS research. We know that a protein called heterogeneous nuclear ribonucleoprotein A1 ('A1') plays an essential role in promoting nerve cell health and connectivity. We have previously shown that these functions of A1 are impaired in brains of people with MS which injures nerve cells and alters other processes important for synapses. We therefore hypothesize that impaired A1 function contributes to MS by disrupting nerve cell connections. Our next steps are to study how A1 affects nerve cell communication in MS experimentally. I will model impaired A1 function by removing A1 from nerve cells in the mouse brain and from nerve cells grown in a dish. Using a powerful microscope and different measures of synapse function, including behaviour studies, I will define how nerve cell connectivity and brain function are disrupted with impaired A1 function in MS. This work is important because it will help us understand how cognitive symptoms occur with disease worsening and provide new avenues for therapies that could protect brain function in persons living with MS.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
559803
Name
Messmer Miranda L
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Investigating the molecular mechanisms of synaptic pathology in multiple sclerosis through dysfunction of heterogeneous nuclear ribonucleoprotein A1
Programtype2
Studentship Programs
Orgnameinp2
University of Saskatchewan
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Confocal Microscopy; Crispr; Heterogeneous Nuclear Ribonucleoprotein A1; Multiple Sclerosis; Neurodegeneration; Neurological Disease; Neuroscience; Rna Binding Protein; Rna Sequencing; Synapse
Abstract
Multiple sclerosis (MS) is an inflammatory disease that causes chronic damage to the brain and spinal cord. Damage to nerve cells is what drives long-term disability and disease worsening. Research has shown that the tiny connections between nerve cells, called synapses, are also affected in the brains of people living with MS. Synapses are essential for communication in the brain because they allow nerve cells to send signals that control movement, memory, and cognition. In MS, these connections become disrupted or lost, which contributes to depression, fatigue, and difficulties with learning, memory, and challenges in performing daily activities. However, there are no available therapies for protecting brain function because we do not fully understand how nerve cell connections are lost. Our lab focuses on studying nerve cells, with the goal of addressing this knowledge and therapeutic gap in MS research. We know that a protein called heterogeneous nuclear ribonucleoprotein A1 ('A1') plays an essential role in promoting nerve cell health and connectivity. We have previously shown that these functions of A1 are impaired in brains of people with MS which injures nerve cells and alters other processes important for synapses. We therefore hypothesize that impaired A1 function contributes to MS by disrupting nerve cell connections. Our next steps are to study how A1 affects nerve cell communication in MS experimentally. I will model impaired A1 function by removing A1 from nerve cells in the mouse brain and from nerve cells grown in a dish. Using a powerful microscope and different measures of synapse function, including behaviour studies, I will define how nerve cell connectivity and brain function are disrupted with impaired A1 function in MS. This work is important because it will help us understand how cognitive symptoms occur with disease worsening and provide new avenues for therapies that could protect brain function in persons living with MS.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Messmer, Miranda L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~